PEP Health has been chosen as one of sixteen digital health and medical device startups founded in the United Kingdom for a customized accelerator at the Texas Medical Center's Innovation Factory.
In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.
The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries. We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator. Ashley McPhail Chief external affairs and administration officer - TMC
The 16 companies will participate in the program from June to November. The cohort arrived in Houston on June 5 and has access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US.
We're delighted to have been selected to join this highly respected program after a very competitive process. The timing of this program and the invaluable support provided will help us further as we continue to expand and spread in the USA. Mark Lomax CEO - PEP Health
